Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in HCC Patients With GALNT14-rs9679162-non-TT Genotype

NCT03608878 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class

Stopped The biopsies in the first 5 screened patients were all negative for Globo-H, of which positive is required to include the patients.

Conditions

Interventions

Sponsor

Chang Gung Memorial Hospital